New studies in rats suggest the drug reserpine, approved in 1955 for high blood pressure, might treat the blinding disease ...

Researchers have developed a groundbreaking eye drop treatment that slows vision loss in animal models of retinitis pigmentosa, a group of inherited diseases that cause progressive blindness in humans ...

Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The compounds, described in a study published January 14 in the open-access ...

Two-year data with eyeDNA Therapeutics’ gene therapy for retinitis pigmentosa (RP), an inherited form of blindness, has prompted the biotech to seek discussions with regulators about the design ...

Scientists have for the first time looked deep into the protein structure that may determine our vision—and discovered that ...

Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa (RP) that can be used regardless of ...

"We are excited by the therapeutic benefits seen in retinitis pigmentosa patients with progressive and permanent loss of photoreceptors and without any treatment option," said Dr. Santosh ...